Danco Statement on Filing of Cert Petition, September 8, 2023



NEW YORK, Sept. 8, 2023 /PRNewswire/ — Today, Danco filed a cert petition asking the Supreme Court to review the Fifth Circuit’s decision invalidating changes FDA approved to the conditions of use for Mifeprex® in 2016 and in 2021. That decision is inconsistent with established Supreme…

Leave a Reply